Editorials “Liquid biopsy” for cancer screening BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.m4933 (Published 04 January 2021) Cite this as: BMJ 2021;372:m4933 Article Related content Metrics Responses Peer review Related articles Research Methods & Reporting The spectrum effect in tests for risk prediction, screening, and diagnosis Published: 22 June 2016; BMJ 353 doi:10.1136/bmj.i3139 Views & Reviews Screening the healthy population for covid-19 is of unknown value, but is being introduced nationwide Published: 19 November 2020; BMJ 371 doi:10.1136/bmj.m4438 Letter Grail’s reply to editorial on “liquid biopsy” for cancer screening Published: 03 March 2021; BMJ 372 doi:10.1136/bmj.n596 See more George Watt Cardno BMJ March 28, 2023, 380 p726; DOI: https://doi.org/10.1136/bmj.p726 How covid-19 bolstered an already perverse publishing system BMJ March 28, 2023, 380 p689; DOI: https://doi.org/10.1136/bmj.p689 Patients launch legal action against AstraZeneca over its covid-19 vaccine BMJ March 28, 2023, 380 p725; DOI: https://doi.org/10.1136/bmj.p725 Why I . . . do combat sports BMJ March 28, 2023, 380 p417; DOI: https://doi.org/10.1136/bmj.p417 Helen Salisbury: Taking risks with our health service BMJ March 28, 2023, 380 p716; DOI: https://doi.org/10.1136/bmj.p716 Cited by... ctDNA detection by personalised assays in early-stage NSCLCAbstract Fulltext PDF
